MARKET

CSBR

CSBR

Champions
NASDAQ

Real-time Quotes | Nasdaq Last Sale

10.58
+0.17
+1.63%
Opening 15:39 07/28 EDT
OPEN
10.49
PREV CLOSE
10.41
HIGH
10.87
LOW
10.49
VOLUME
7.78K
TURNOVER
--
52 WEEK HIGH
14.68
52 WEEK LOW
7.05
MARKET CAP
141.67M
P/E (TTM)
516.10
1D
5D
1M
3M
1Y
5Y
Champions Oncology Announces an Expanded Corporate Strategy to Include Drug Discovery and Development
HACKENSACK, NJ / ACCESSWIRE / July 26, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology solutions provider that is transforming drug discovery through innovative pharmacology, biomarker, and data platforms, announced toda...
ACCESSWIRE · 2d ago
BRIEF-Champions Biotechnology Says Q4 Revenue Increased 21% To $10.6 Mln
reuters.com · 6d ago
Champions Oncology beats on revenue
Champions Oncology (CSBR): Q4 Non-GAAP EPS of -$0.03; GAAP EPS of -$0.04.Revenue of $10.6M (+20.5% Y/Y) beats by $0.57M.Press Release
Seekingalpha · 6d ago
Champions Oncology Reports Quarterly Revenue of $10.6 Million
ACCESSWIRE · 6d ago
-- Earnings Flash (CSBR) CHAMPIONS ONCOLOGY Reports Q4 Loss $-0.03
MT Newswires · 6d ago
Earnings Scheduled For July 22, 2021
  Companies Reporting Before The Bell • Champions Oncology, Inc. - Common Stock (NASDAQ:CSBR) is estimated to report earnings for its fourth quarter.
Benzinga · 6d ago
2 Top Biotech Stocks to Buy Under $10
StockNews.com · 07/15 09:39
Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 22, 2021
HACKENSACK, NJ / ACCESSWIRE / July 14, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology solutions provider engaged in transforming drug discovery through innovative pharmacology, biomarker and data platforms, today announ...
ACCESSWIRE · 07/14 12:30
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CSBR. Analyze the recent business situations of Champions through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CSBR stock price target is 15.67 with a high estimate of 17.00 and a low estimate of 14.00.
EPS
Institutional Holdings
Institutions: 67
Institutional Holdings: 10.15M
% Owned: 75.82%
Shares Outstanding: 13.39M
TypeInstitutionsShares
Increased
19
266.59K
New
1
713
Decreased
15
65.59K
Sold Out
3
131.93K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+3.65%
Pharmaceuticals & Medical Research
+1.99%
Key Executives
Chairman/Director
Joel Ackerman
Chief Executive Officer/Director
Ronnie Morris
Chief Financial Officer
David Miller
Lead Director/Independent Director
David Sidransky
Director
Robert Brainin
Independent Director
Philip Breitfeld
Independent Director
Daniel Mendelson
Independent Director
Scott Tobin
No Data
  • All
  • Financials
  • Insiders
More
About CSBR
Champions Oncology, Inc. is engaged in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The Company’s TumorGraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The Company uses this technology, in conjunction with related services, to offer solutions for two consumer groups: Translational Oncology Solutions (TOS) and Personalized Oncology Solutions (POS). The Company’s TOS business offers a technology platform to pharmaceutical and biotechnology companies using TumorGraft studies. POS assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The Company subsidiaries include Champions Oncology (Israel) and Limited and Champions Biotechnology U.K., Limited.

Webull offers kinds of Champions Oncology Inc stock information, including NASDAQ:CSBR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CSBR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CSBR stock methods without spending real money on the virtual paper trading platform.